Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the effect of Niacin/Laropiprant on postprandial
lipoprotein metabolism, postprandial glucose metabolism, postprandial monocyte function, and
postprandial biomarkers of endothelial dysfunction and inflammation.